Pleural transudate: pathophysiology during superior vena cava syndrome. Issue 1 (25th February 2019)

• Record Type: Journal Article
• Authors: Basille, Damien; Chevalier, Kevin; Andrejak, Claire; Jounieaux, Vincent
• Is Part Of: ERJ open research. Volume 5:Issue 1(2019)
• Publication Date: 2019-02-25
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; Respiration; Respiratory organs -- Diseases; Respiratory organs -- Diseases -- Treatment; Respiratory Tract Diseases; Electronic journals; Fulltext; Internet Resources; Periodicals; Periodical; 616.2005
• DOI: 10.1183/23120541.00251-2018
• Languages: English
• ISSNs: 2312-0541

Abstract

Pathophysiology, diagnosis and treatment of pleural transudates has widely been described in the literature [1–3]. Except for left heart failure, which requires diuretics, thoracoscopic talc pleurodesis appears to be a safe and effective therapeutic option [4–6]. We report the case of a woman who presented with a sudden pleural fluid formation from her parietal pleura during a talc pleurodesis for a recurrent transudative pleural effusion. We discuss the pathophysiology of this phenomenon. Pleural transudative effusion arises from imbalances between the hydrostatic and/or oncotic pressures. Temperature drop following talc poudrage through a spray may accentuate the pressure changes induced by superior vena cava syndrome. http://ow.ly/EpZm30nwVZj